Kathryn L Rice

Summary

Country: USA

Publications

  1. pmc Role of tiotropium in the treatment of COPD
    Kathryn L Rice
    University of Minnesota, Minneapolis, MN, USA
    Int J Chron Obstruct Pulmon Dis 2:95-105. 2007
  2. doi request reprint Responses to tiotropium in African-American and Caucasian patients with chronic obstructive pulmonary disease
    Kathryn L Rice
    Veterans Affairs Medical Center, Minneapolis, Minnesota 55417, USA
    Transl Res 152:88-94. 2008
  3. doi request reprint Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial
    Kathryn L Rice
    Pulmonary Section, Department of Medicine, VA Medical Center, Minneapolis, Minnesota 55417, USA
    Am J Respir Crit Care Med 182:890-6. 2010
  4. doi request reprint Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study
    Ken M Kunisaki
    Division of Pulmonary, Allergy, Critical Care and Sleep, University of Minnesota, USA
    Ther Adv Respir Dis 2:55-64. 2008
  5. ncbi request reprint Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidence
    Ken M Kunisaki
    University of Minnesota, Minneapolis, Minnesota, USA
    Drugs Aging 24:303-24. 2007
  6. doi request reprint Economic evaluation of a disease management program for chronic obstructive pulmonary disease
    Naresh A Dewan
    Pulmonary Section, Department of Medicine, VA Medical Center, Omaha, Nebraska 68105, USA
    COPD 8:153-9. 2011
  7. ncbi request reprint Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit
    Douglas D DeCarolis
    Department of Pharmacy, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota 55417, USA
    Pharmacotherapy 27:510-8. 2007
  8. ncbi request reprint Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study
    Geoffrey J Gorse
    Department of Veterans Affairs, Medical Center, Saint Louis University, St Louis, MO, USA
    Vaccine 21:2133-44. 2003

Collaborators

Detail Information

Publications8

  1. pmc Role of tiotropium in the treatment of COPD
    Kathryn L Rice
    University of Minnesota, Minneapolis, MN, USA
    Int J Chron Obstruct Pulmon Dis 2:95-105. 2007
    ..Medico economic analyses suggest that treatment with tiotropium may also be cost-effective, primarily by reducing costs associated with hospitalizations...
  2. doi request reprint Responses to tiotropium in African-American and Caucasian patients with chronic obstructive pulmonary disease
    Kathryn L Rice
    Veterans Affairs Medical Center, Minneapolis, Minnesota 55417, USA
    Transl Res 152:88-94. 2008
    ..African Americans used fewer respiratory medications than Caucasians in this study. We conclude that tiotropium reduces COPD exacerbations and associated health-care use to a similar extent in African Americans compared with Caucasians...
  3. doi request reprint Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial
    Kathryn L Rice
    Pulmonary Section, Department of Medicine, VA Medical Center, Minneapolis, Minnesota 55417, USA
    Am J Respir Crit Care Med 182:890-6. 2010
    ..Objectives: To determine whether a simplified disease management program reduces hospital admissions and emergency department (ED) visits due to COPD...
  4. doi request reprint Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study
    Ken M Kunisaki
    Division of Pulmonary, Allergy, Critical Care and Sleep, University of Minnesota, USA
    Ther Adv Respir Dis 2:55-64. 2008
    ..We evaluated the ability of exhaled nitric oxide (FENO) and serum inflammatory markers (C-reactive protein [CRP], interleukin-6 [IL-6], and interleukin-8 [IL-8]) to independently predict spirometric responses to ICS in patients with COPD...
  5. ncbi request reprint Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly : an appraisal of published evidence
    Ken M Kunisaki
    University of Minnesota, Minneapolis, Minnesota, USA
    Drugs Aging 24:303-24. 2007
    ..Mucolytic agents, pulmonary rehabilitation, and case management programmes may also reduce exacerbation risk, but the current evidence supporting these interventions is weaker...
  6. doi request reprint Economic evaluation of a disease management program for chronic obstructive pulmonary disease
    Naresh A Dewan
    Pulmonary Section, Department of Medicine, VA Medical Center, Omaha, Nebraska 68105, USA
    COPD 8:153-9. 2011
    ..The objectives of this study were to determine the cost of implementing the DM program and its impact on healthcare resource utilization costs compared to UC in high-risk COPD patients...
  7. ncbi request reprint Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit
    Douglas D DeCarolis
    Department of Pharmacy, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota 55417, USA
    Pharmacotherapy 27:510-8. 2007
    ..To compare outcomes of treating alcohol withdrawal delirium (AWD) with a symptom-driven benzodiazepine protocol versus nonprotocol benzodiazepine infusions in the intensive care unit (ICU)...
  8. ncbi request reprint Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study
    Geoffrey J Gorse
    Department of Veterans Affairs, Medical Center, Saint Louis University, St Louis, MO, USA
    Vaccine 21:2133-44. 2003
    ..17, 0.53), and -0.05 for type B virus (95% CL: -1.13, 0.48). However, there was a possible advantage for TC over TP in reducing respiratory consequences of an influenza season measured by pulmonary function and symptoms at end of study...